about
Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for womenWhat number of oocytes is appropriate for defining poor ovarian response?Efficacy of random-start controlled ovarian stimulation in cancer patientsEffects of three different types of antifreeze proteins on mouse ovarian tissue cryopreservation and transplantation.In vitro fertilization outcomes in women with surgery induced diminished ovarian reserve after endometrioma operation: Comparison with diminished ovarian reserve without ovarian surgery.Chapter 4 Role of Antioxidants and Antifreeze Proteins in Cryopreservation/Vitrification.Chapter 2 Utility of Animal Models for Human Ovarian Tissue Cryopreservation.Ovary is necessary to the health of uterus.Proteomic analysis of human follicular fluid in poor ovarian responders during in vitro fertilization.Successful in Vitro Fertilization and Embryo Transfer after Transplantation of Cryopreserved Ovarian Tissue: Report of the First Korean Case.The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins.Effect of Sperm DNA Fragmentation on Embryo Quality in Normal Responder Women in In Vitro Fertilization and Intracytoplasmic Sperm InjectionManagement of endometriosis-related infertility: Considerations and treatment optionsA survey on the awareness and knowledge about elective oocyte cryopreservation among unmarried women of reproductive age visiting a private fertility centerPredictors of blastocyst formation rate in elective day 5 transfer cycleUterine Leiomyoma Is Associated with Female Sexual Dysfunction in Postmenopausal WomenErratum: Correction of Author ORCID in the Article: Efficacy of Random-start Controlled Ovarian Stimulation in Cancer Patients
P50
Q26771979-269DE7E4-A5D7-47F9-A082-EB5062AED0FFQ35086102-42D741F6-1471-4842-BDB5-FB30B2A822BEQ35089325-2278DB1A-26FC-464D-8066-F784767EDAC2Q35566786-5BC5F089-0170-47F5-A25C-9EDF6895874EQ37647340-5226EBD0-3EAA-4F8D-93B1-63AADE2C4413Q41597221-92CBF8A7-B544-464F-A791-E5DFA8298316Q41597236-107BB65B-177E-4689-B60E-1E6C67161501Q42913861-B05CD02C-E363-4BF4-9AE8-34B72B89B429Q47993047-21BBDA7D-6B61-49BB-8B39-63AA4AE1848AQ54941908-47EFDEEC-C418-43CF-AB65-7C9C20558F7BQ55001778-673E40A7-5182-4B3D-9933-8875DE3CB6F2Q64101499-A4074747-33B8-40D6-8752-D8EDB4D1FF28Q89846512-54E002F1-54C2-4826-B82E-D847FB2F0E1DQ91503136-06C38154-9210-4381-8753-92CEF8954988Q91610162-BE1568D7-E270-4913-8EE8-FD8DECCB75CBQ92195742-B94E2C3E-0B71-41A6-AC30-42A26A9E2E33Q96020372-AD24F96B-6B40-40CE-B5AA-E57C10A1EC85
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Seul Ki Kim
@ast
Seul Ki Kim
@en
Seul Ki Kim
@es
Seul Ki Kim
@nl
Seul Ki Kim
@sl
type
label
Seul Ki Kim
@ast
Seul Ki Kim
@en
Seul Ki Kim
@es
Seul Ki Kim
@nl
Seul Ki Kim
@sl
prefLabel
Seul Ki Kim
@ast
Seul Ki Kim
@en
Seul Ki Kim
@es
Seul Ki Kim
@nl
Seul Ki Kim
@sl
P106
P1153
56107871900
P31
P496
0000-0002-1647-6711